Feedback / Questions
BOLD-100 - Bold Therap, Intezyne
https://www.prnewswire.com/news-releases/bold-therapeutics-to-present-best-in-class-phase-2-metastatic-colorectal-cancer-data-at-aacr-2023-301796021.html
Apr 13, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next